United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $831,715,183.10
- April 14, 2025
- Martine A Rothblatt
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 21, 2023 | EVP | 6,000 | $222.19 | Sell | $1,333,140.00 | |
| Sept. 13, 2023 | Director | 383 | $222.36 | Sell | $85,163.88 | |
| Sept. 7, 2023 | EVP | 6,000 | $222.98 | Sell | $1,337,880.00 | |
| Aug. 3, 2023 | EVP | 6,000 | $236.25 | Sell | $1,417,500.00 | |
| July 20, 2023 | EVP | 2,500 | $243.87 | Sell | $609,675.00 | |
| July 6, 2023 | EVP | 6,000 | $215.19 | Sell | $1,291,140.00 | |
| June 15, 2023 | EVP | 6,000 | $227.77 | Sell | $1,366,620.00 | |
| June 1, 2023 | EVP | 6,000 | $209.11 | Sell | $1,254,660.00 | |
| May 18, 2023 | EVP | 6,000 | $214.58 | Sell | $1,287,480.00 | |
| May 5, 2023 | Director | 374 | $214.81 | Sell | $80,338.94 | |
| May 4, 2023 | EVP | 6,000 | $215.82 | Sell | $1,294,920.00 | |
| May 1, 2023 | CEO | 8,000 | $231.40 | Sell | $1,851,200.00 | |
| April 28, 2023 | CEO | 8,000 | $229.32 | Sell | $1,834,560.00 | |
| April 26, 2023 | CEO | 8,000 | $226.01 | Sell | $1,808,080.00 | |
| April 24, 2023 | CEO | 8,000 | $228.64 | Sell | $1,829,120.00 | |
| April 21, 2023 | CEO | 8,000 | $228.82 | Sell | $1,830,560.00 | |
| April 20, 2023 | EVP | 6,000 | $223.96 | Sell | $1,343,760.00 | |
| April 19, 2023 | CEO | 8,000 | $226.12 | Sell | $1,808,960.00 | |
| April 17, 2023 | CEO | 8,000 | $230.47 | Sell | $1,843,760.00 | |
| April 13, 2023 | CEO | 8,000 | $230.69 | Sell | $1,845,520.00 | |
| April 11, 2023 | CEO | 8,000 | $225.57 | Sell | $1,804,560.00 | |
| April 6, 2023 | CEO | 8,000 | $229.12 | Sell | $1,832,960.00 | |
| April 6, 2023 | EVP | 6,000 | $232.79 | Sell | $1,396,740.00 | |
| April 4, 2023 | CEO | 8,000 | $226.26 | Sell | $1,810,080.00 | |
| March 30, 2023 | CEO | 8,000 | $217.14 | Sell | $1,737,120.00 | |
| March 27, 2023 | CEO | 8,000 | $217.04 | Sell | $1,736,320.00 | |
| March 24, 2023 | CEO | 8,000 | $217.95 | Sell | $1,743,600.00 | |
| March 22, 2023 | CEO | 8,000 | $216.01 | Sell | $1,728,080.00 | |
| March 20, 2023 | CEO | 8,000 | $223.96 | Sell | $1,791,680.00 | |
| March 17, 2023 | CEO | 8,000 | $217.91 | Sell | $1,743,280.00 | |
| March 16, 2023 | EVP | 6,000 | $214.39 | Sell | $1,286,340.00 | |
| March 9, 2023 | CEO | 8,000 | $222.63 | Sell | $1,781,040.00 | |
| March 7, 2023 | CEO | 8,000 | $239.16 | Sell | $1,913,280.00 | |
| March 2, 2023 | CEO | 8,000 | $244.50 | Sell | $1,956,000.00 | |
| Feb. 27, 2023 | CEO | 8,000 | $249.14 | Sell | $1,993,120.00 | |
| Feb. 24, 2023 | CEO | 8,000 | $249.27 | Sell | $1,994,160.00 | |
| Feb. 22, 2023 | CEO | 8,000 | $246.77 | Sell | $1,974,160.00 | |
| Feb. 13, 2023 | CEO | 8,000 | $254.76 | Sell | $2,038,080.00 | |
| Feb. 8, 2023 | CEO | 8,000 | $253.38 | Sell | $2,027,040.00 | |
| Feb. 2, 2023 | EVP | 6,000 | $254.63 | Sell | $1,527,780.00 | |
| Feb. 1, 2023 | Director | 700 | $261.33 | Sell | $182,931.00 | |
| Jan. 31, 2023 | CEO | 8,000 | $261.50 | Sell | $2,092,000.00 | |
| Jan. 27, 2023 | CEO | 8,000 | $260.01 | Sell | $2,080,080.00 | |
| Jan. 25, 2023 | CEO | 8,000 | $264.21 | Sell | $2,113,680.00 | |
| Jan. 23, 2023 | CEO | 8,000 | $258.97 | Sell | $2,071,760.00 | |
| Jan. 19, 2023 | CEO | 8,000 | $259.60 | Sell | $2,076,800.00 | |
| Jan. 19, 2023 | EVP | 6,000 | $258.95 | Sell | $1,553,700.00 | |
| Jan. 17, 2023 | CEO | 8,000 | $260.50 | Sell | $2,084,000.00 | |
| Jan. 13, 2023 | CEO | 8,000 | $261.52 | Sell | $2,092,160.00 | |
| Jan. 11, 2023 | CEO | 8,000 | $261.39 | Sell | $2,091,120.00 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, Raymond Dwek, John Maxim Ferrari, Christopher Patusky, Paul Mahon, David Zaccardelli, Michael Benkowitz, Richard Giltner, Nilda Mesa, James Edgemond, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Ray Kurzweil, Paul A. Mahon, Judy D. Olian, R Paul Gray, MAHON PAUL A, Louis Sullivan, Tommy G. Thompson, and DWEK RAYMOND
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on April 14, 2025.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Louis W Sullivan with a total value of $9,781,722.98 on Dec. 18, 2024.